An Open Label Randomized Phase IV Study of the Safety and Efficacy of ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis
Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 18 May 2018
Price : $35 *
At a glance
- Drugs Corticotropin (Primary)
- Indications Lupus nephritis
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 05 May 2018 Status changed from recruiting to withdrawn prior to enrolment.
- 28 Mar 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Feb 2018, according to ClinicalTrials.gov record.